Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Delayed Quote USD

Aerovate Therapeutics, Inc. (AVTE)

Compare
2.4900
-0.0200
(-0.80%)
At close: April 4 at 4:00:02 PM EDT
2.4900
0.00
(0.00%)
After hours: April 4 at 4:46:38 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
74,596
74,596
81,409
53,237
23,022
Operating Income
-74,596
-74,596
-81,409
-53,237
-23,022
Net Non Operating Interest Income Expense
5,042
5,042
5,945
1,830
65
Other Income Expense
-19
-19
-1
-79
-3
Pretax Income
-69,573
-69,573
-75,465
-51,486
-22,960
Tax Provision
55
55
56
25
3
Net Income Common Stockholders
-69,628
-69,628
-75,521
-51,511
-22,985
Diluted NI Available to Com Stockholders
-69,628
-69,628
-75,521
-51,511
-22,985
Basic EPS
-2.44
--
-2.87
-2.10
-1.87
Diluted EPS
-2.44
--
-2.87
-2.10
-1.87
Basic Average Shares
28,582.1940
--
26,331.6300
24,472.1040
12,293.6290
Diluted Average Shares
28,582.1940
--
26,331.6300
24,472.1040
12,293.6290
Total Operating Income as Reported
-74,596
-74,596
-81,409
-53,237
-23,022
Total Expenses
74,596
74,596
81,409
53,237
23,022
Net Income from Continuing & Discontinued Operation
-69,628
-69,628
-75,521
-51,511
-22,963
Normalized Income
-69,628
-69,628
-75,521
-51,511
-22,963
Interest Income
5,042
5,042
5,945
1,830
65
Net Interest Income
5,042
5,042
5,945
1,830
65
EBIT
-74,596
-74,596
-81,409
-53,237
-23,022
EBITDA
-74,314
-74,314
-81,313
-53,169
-23,007
Reconciled Depreciation
282
282
96
68
15
Net Income from Continuing Operation Net Minority Interest
-69,628
-69,628
-75,521
-51,511
-22,963
Normalized EBITDA
-74,314
-74,314
-81,313
-53,169
-23,007
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
12/31/2021 - 6/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers